News May 3, 2023
BURLINGTON, Mass. and JERUSALEM, May 03, 2023 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE:...
News May 2, 2023
New Research on Deep TMS Depression Treatment to be Presented BURLINGTON, Mass. and JERUSALEM, Israel,...
News March 28, 2023
BURLINGTON, Mass. and JERUSALEM, March 28, 2023 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...
News March 15, 2023
BURLINGTON, Mass. and JERUSALEM, March 15, 2023 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...
News March 2, 2023
BURLINGTON, Mass. and JERUSALEM, March 02, 2023 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...
News March 1, 2023
BURLINGTON, Mass. and JERUSALEM, Israel, March 01, 2023 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ &...
News February 23, 2023
BURLINGTON, Mass. and JERUSALEM, Feb. 23, 2023 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...
News February 13, 2023
BURLINGTON, Mass. and JERUSALEM, Feb. 13, 2023 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...
News February 13, 2023
David Zacut, M.D., Relinquishing Chairman Role Held Since Company’s Inception, to Now Serve as Board...
News January 31, 2023
Study Results Outline a Potential Path to More Personalized Medicine in Noninvasive Brain Stimulation BURLINGTON,...
News January 11, 2023
BURLINGTON, MA and JERUSALEM, Israel, Jan. 11, 2023 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ &...
News January 10, 2023
BURLINGTON, Mass. and JERUSALEM, Jan. 10, 2023 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...
News December 13, 2022
BURLINGTON, Mass. and JERUSALEM, Dec. 13, 2022 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...
News November 28, 2022
BURLINGTON, Mass. and JERUSALEM, November 28, 2022 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ &...
News November 16, 2022
Conference call to be held today, November 16, 2022, at 8:30 AM ET ...
News November 3, 2022
Reflects Broader Trends Significantly Increasing Access to Deep TMS for OCD and Depression Patients BURLINGTON,...
News November 2, 2022
BURLINGTON, Mass. and JERUSALEM, Nov. 02, 2022 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...
News November 1, 2022
Dr. Hanlon has Served as a Leader in Brain Stimulation Research for Nearly 20 Years BURLINGTON, Mass....